Resazurin Cell Viability Assay provides a homogeneous, fluorescent method for monitoring cell viability. It uses the indicator dye resazurin to measure the metabolic capacity of cells – an indicator of cell viability. Viable cells retain the ability to reduce resazurin into resorufin, which is highly fluorescent. Nonviable cells rapidly lose metabolic capacity, do not reduce the indicator dye, and thus do not generate a fluorescent signal. The homogeneous assay procedure involves adding the single reagent directly to cells cultured in a serum-supplemented medium. After an incubation step, data are recorded using either a plate-reading fluorometer (570Ex/590Em) or spectrophotometer (Resazurin 605nm /Resorufin 573nm). However, fluorescence is the preferred method because it is more sensitive and involves fewer data calculations. Therefore, the fluorescence intensity observed in this assay is a true measure of the viable cells. The reagent is compatible with all culture media and with all liquid handling systems for high-throughput screening applications in 96-well and 384-well plates.
ApplicationsStore the reagent at –20℃ protected from light. For frequent use, the product may be kept tightly capped at 4℃ or at ambient temperature (22-25℃) for 6-8 weeks. Shelf life: 12 months.
Additional information
SIZE (test) | 10K Tests, 2000 Tests, 5000 Tests |
---|
Datasheet:
TBS2001_Resazruine cell viability_assay_v03_2021
MSDS:
TBS2001 Cell Viability Assay Kit SDS
TribioScience 是一家私人控股的生物技术公司,于 2010 年创立。我们的使命是让科学家在实验室的工作更轻松、更省时。我们专注于为分子生物学、生物化学、免疫学、传染病、基因治疗、神经科学、动物实验和药物开发领域的生命科学研究实验室和生物技术公司提供高质量的产品。我们的团队成员拥有超过 50 年的综合经验,我们还作为 CRO(研究合同组织)为生物技术行业和学术界提供服务。我们的动物建模服务已被用于 高排名大学的动物模型开发和体内评估。
TribioScience is a privately held biotech founded in 2010 by a group of scientists at Stanford University. Our mission is to make scientists’ jobs in the laboratory easier and less time-consuming. We focus on offering high-quality products for life science research laboratories and biotech companies in the areas of molecular biology, biochemistry, immunology, infectious disease, gene therapy, neuroscience, animal experiment, and drug development.